Tower Research Capital (TRC)’s Calithera Biosciences, Inc CALA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,647
| Closed | -$8K | – | 6948 |
|
|
2022
Q3 | $8K | Sell |
2,647
-11,856
| -82% | -$40.5K | ﹤0.01% | 4853 |
|
|
2022
Q2 | $36K | Buy |
+14,503
| New | +$67.2K | ﹤0.01% | 3203 |
|
|
2022
Q1 | – | Sell |
-440
| Closed | -$6K | – | 7083 |
|
|
2021
Q4 | $6K | Sell |
440
-772
| -64% | -$19.4K | ﹤0.01% | 5115 |
|
|
2021
Q3 | $53K | Buy |
1,212
+181
| +18% | +$7.81K | ﹤0.01% | 2929 |
|
|
2021
Q2 | $43K | Buy |
1,031
+78
| +8% | +$3.43K | ﹤0.01% | 3160 |
|
|
2021
Q1 | $46K | Sell |
953
-166
| -15% | -$9.66K | ﹤0.01% | 3205 |
|
|
2020
Q4 | $110K | Sell |
1,119
-2,535
| -69% | -$222K | ﹤0.01% | 2256 |
|
|
2020
Q3 | $252K | Buy |
3,654
+3,027
| +483% | +$264K | ﹤0.01% | 2343 |
|
|
2020
Q2 | $66K | Buy |
+627
| New | +$74.5K | ﹤0.01% | 2834 |
|
|
2020
Q1 | – | Sell |
-66
| Closed | -$7K | – | 4254 |
|
|
2019
Q4 | $7K | Sell |
66
-137
| -67% | -$10.3K | ﹤0.01% | 2559 |
|
|
2019
Q3 | $12K | Sell |
203
-521
| -72% | -$41.7K | ﹤0.01% | 2847 |
|
|
2019
Q2 | $56K | Buy |
+724
| New | +$82.2K | ﹤0.01% | 1525 |
|
|
2019
Q1 | – | Sell |
-54
| Closed | -$4K | – | 4516 |
|
|
2018
Q4 | $4K | Sell |
54
-150
| -74% | -$14.8K | ﹤0.01% | 3102 |
|
|
2018
Q3 | $21K | Buy |
204
+176
| +629% | +$16.8K | ﹤0.01% | 2323 |
|
|
2018
Q2 | $3K | Buy |
+28
| New | +$3.17K | ﹤0.01% | 3274 |
|
|
2018
Q1 | – | Sell |
-113
| Closed | -$19K | – | 4056 |
|
|
2017
Q4 | $19K | Buy |
113
+104
| +1,156% | +$26.6K | ﹤0.01% | 2133 |
|
|
2017
Q3 | $3K | Sell |
9
-76
| -89% | -$24K | ﹤0.01% | 3511 |
|
|
2017
Q2 | $25K | Sell |
85
-209
| -71% | -$55.9K | ﹤0.01% | 1115 |
|
|
2017
Q1 | $68K | Buy |
+294
| New | +$50.8K | 0.01% | 606 |
|
|
2016
Q4 | – | Sell |
-85
| Closed | -$6K | – | 4592 |
|
|
2016
Q3 | $6K | Buy |
85
+35
| +70% | +$2.26K | ﹤0.01% | 2470 |
|
|
2016
Q2 | $4K | Buy |
50
+1
| +2% | +$100 | ﹤0.01% | 3584 |
|
|
2016
Q1 | $5K | Sell |
49
-51
| -51% | -$5.78K | ﹤0.01% | 2771 |
|
|
2015
Q4 | $15K | Sell |
100
-48
| -32% | -$7.2K | ﹤0.01% | 1641 |
|
|
2015
Q3 | $16K | Buy |
+148
| New | +$19.2K | ﹤0.01% | 1943 |
|
|
2015
Q2 | – | Sell |
-26
| Closed | -$9K | – | 5236 |
|
|
2015
Q1 | $9K | Sell |
26
-125
| -83% | -$44.5K | ﹤0.01% | 2891 |
|
|
2014
Q4 | $61K | Buy |
+151
| New | +$39.4K | 0.01% | 930 |
|
Other funds holding CALA
BI
TCMG
Tower Research Capital (TRC)'s CALA Position: Q4 2022 in Review
Tower Research Capital (TRC) sold out of Calithera Biosciences, Inc (CALA) in Q4 2022, closing a stake of 2,647 shares — an estimated $8K sold.
Tower Research Capital (TRC) first reported a position in CALA in Q4 2014 and held it in 26 quarters. The position peaked at $252K in Q3 2020. 23 funds tracked by Wall St. Rank hold CALA as of Q4 2022.
- Tower Research Capital (TRC) reported no remaining Calithera Biosciences, Inc position as of Q4 2022 after selling out during the quarter.
- Tower Research Capital (TRC) sold 2,647 Calithera Biosciences, Inc shares in Q4 2022, an estimated $8K.
- Tower Research Capital (TRC) first reported a position in Calithera Biosciences, Inc in Q4 2014 and held it in 26 quarters.
- Tower Research Capital (TRC)'s Calithera Biosciences, Inc position peaked at $252K in Q3 2020.
- 23 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q4 2022.
Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.